Prevalence and burden of bipolar disorders in European countries
- PMID: 15935623
- DOI: 10.1016/j.euroneuro.2005.04.011
Prevalence and burden of bipolar disorders in European countries
Abstract
A literature search, supplemented by an expert survey and selected reanalyses of existing data from epidemiological studies was performed to determine the prevalence and associated burden of bipolar I and II disorder in EU countries. Only studies using established diagnostic instruments based on DSM-III-R or DSM-IV, or ICD-10 criteria were considered. Fourteen studies from a total of 10 countries were identified. The majority of studies reported 12-month estimates of approximately 1% (range 0.5-1.1%), with little evidence of a gender difference. The cumulative lifetime incidence (two prospective-longitudinal studies) is slightly higher (1.5-2%); and when the wider range of bipolar spectrum disorders is considered estimates increased to approximately 6%. Few studies have reported separate estimates for bipolar I and II disorders. Age of first onset of bipolar disorder is most frequently reported in late adolescence and early adulthood. A high degree of concurrent and sequential comorbidity with other mental disorders and physical illnesses is common. Most studies suggest equally high or even higher levels of impairments and disabilities of bipolar disorders as compared to major depression and schizophrenia. Few data are available on treatment and health care utilization.
Similar articles
-
The epidemiology of panic disorder and agoraphobia in Europe.Eur Neuropsychopharmacol. 2005 Aug;15(4):435-43. doi: 10.1016/j.euroneuro.2005.04.006. Eur Neuropsychopharmacol. 2005. PMID: 15925492
-
Size and burden of depressive disorders in Europe.Eur Neuropsychopharmacol. 2005 Aug;15(4):411-23. doi: 10.1016/j.euroneuro.2005.04.008. Eur Neuropsychopharmacol. 2005. PMID: 15950441
-
Size and burden of mental disorders in Europe--a critical review and appraisal of 27 studies.Eur Neuropsychopharmacol. 2005 Aug;15(4):357-76. doi: 10.1016/j.euroneuro.2005.04.012. Eur Neuropsychopharmacol. 2005. PMID: 15961293 Review.
-
Size and burden of social phobia in Europe.Eur Neuropsychopharmacol. 2005 Aug;15(4):453-62. doi: 10.1016/j.euroneuro.2005.04.002. Eur Neuropsychopharmacol. 2005. PMID: 15921898 Review.
-
Bipolar obsessive-compulsive disorder and personality disorders.Bipolar Disord. 2007 Nov;9(7):722-9. doi: 10.1111/j.1399-5618.2007.00508.x. Bipolar Disord. 2007. PMID: 17988362
Cited by
-
Smartphone-based self-monitoring in bipolar disorder: evaluation of usability and feasibility of two systems.Int J Bipolar Disord. 2019 Jan 4;7(1):1. doi: 10.1186/s40345-018-0134-8. Int J Bipolar Disord. 2019. PMID: 30610400 Free PMC article.
-
Forecasting Mood in Bipolar Disorder From Smartphone Self-assessments: Hierarchical Bayesian Approach.JMIR Mhealth Uhealth. 2020 Apr 1;8(4):e15028. doi: 10.2196/15028. JMIR Mhealth Uhealth. 2020. PMID: 32234702 Free PMC article. Clinical Trial.
-
Perception of inpatients following remission of a manic episode in bipolar I disorder on a group-based Psychoeducation program: a qualitative study.BMC Psychiatry. 2018 Jan 30;18(1):26. doi: 10.1186/s12888-018-1614-1. BMC Psychiatry. 2018. PMID: 29378562 Free PMC article.
-
Smartphone-based objective monitoring in bipolar disorder: status and considerations.Int J Bipolar Disord. 2018 Jan 23;6(1):6. doi: 10.1186/s40345-017-0110-8. Int J Bipolar Disord. 2018. PMID: 29359252 Free PMC article. Review.
-
Early specific cognitive-behavioural psychotherapy in subjects at high risk for bipolar disorders: study protocol for a randomised controlled trial.Trials. 2014 May 8;15:161. doi: 10.1186/1745-6215-15-161. Trials. 2014. PMID: 24886581 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical